Alveolar soft part sarcoma

Active Research Protocols

  1. 08-C-0080 – SARC Global Collaboration: A Phase II Trial of R1507, a Recombinant Human Monoclonal Antibody to the IGF-1 Receptor for the Treatment of Patients with Recurrent or Refractory Ewing's Sarcoma, Synovial Sarcoma, Rhabdomyosarcoma and Other Sarcomas
  2. 09-C-0192 – Phase II Study of Cediranib (AZD2171) in Patients With Alveolar Soft Part Sarcoma
  3. 11-C-0200 – A Phase II Trial In Which Patients With Metastatic Alveolar Soft Part Sarcoma Are Randomized to Either Sunitinib or Cediranib Monotherapy, with Cross-Over at Disease Progression
NOTE: PDF documents require the free
Adobe Reader.
This page was last updated: January 24, 2014